{"name":"Zahoor khan","slug":"zahoor-khan","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Group III - Serratiopeptidase Group","genericName":"Group III - Serratiopeptidase Group","slug":"group-iii-serratiopeptidase-group","indication":"Post-operative inflammation and swelling","status":"phase_3"}]}],"pipeline":[{"name":"Group III - Serratiopeptidase Group","genericName":"Group III - Serratiopeptidase Group","slug":"group-iii-serratiopeptidase-group","phase":"phase_3","mechanism":"Serratiopeptidase is a serine protease enzyme that breaks down non-structural proteins and fibrin, reducing inflammation and promoting tissue repair.","indications":["Post-operative inflammation and swelling","Musculoskeletal pain and inflammation","Sinusitis and ENT inflammation","Fibrocystic breast disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5sdkFnTV9kdFpjSzgyTnVQZXBicjhxS3lzR3g2ZTVkMHFRZGxMT2FIRmRVSGpzbVVtRXAxUVhjOFhqeE9uaXVVNm84S2IxQTRFUC1LOTJpdUVOcWRKNWc?oc=5","date":"2024-05-05","type":"pipeline","source":"ACS Publications","summary":"A Comprehensive Review on Benzofuran Synthesis Featuring Innovative and Catalytic Strategies - ACS Publications","headline":"A Comprehensive Review on Benzofuran Synthesis Featuring Innovative and Catalytic Strategies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNdmtSX3VnZmRld2d1aGMzN3ZMbUMtbjVEU0FxbDh4UzgwT3gwRFZ4M0ZVVjZXTjRVbFItSGd0VC1kQUI0LWIzTkhIaE95LVRUTmp5Wm1LME1Cd19RYXlzOTBfWGY5Y2ZNSUl4dEh1dzdsS1M4ak5JTHlTQUNiMVFhQXcweW1FOEY0R1RxeWlsYWg0N3M?oc=5","date":"2024-02-05","type":"pipeline","source":"Frontiers","summary":"Drug Shortage: Causes, Impact, and Mitigation Strategies - Frontiers","headline":"Drug Shortage: Causes, Impact, and Mitigation Strategies","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}